Black PC, Tangen CM, Singh P, McConkey DJ, et al. Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guerin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605. Eur Urol 2023 Aug 16:S0302-2838(23)03019-1. doi: 10.1016/j.eururo.2023.
PMID: 37596191